/PRNewswire/ ProSomnus Sleep Technologies ("ProSomnus"), the leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA),.
/PRNewswire/ ProSomnus Sleep Technologies ("ProSomnus"), the leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA),.
CrossingBridge Advisors, an investment management company, recently released its second quarter 2022 investor letter. A copy of the same can be downloaded here.
ProSomnus is a pioneer of precision intraoral devices, a new option for treating mild to moderate obstructive sleep apnea (OSA) A number of scientific studies.